Ryan Walsh
Ryan Walsh
E-mail megerősítve itt: connect.carleton.ca
Hivatkozott rá
Hivatkozott rá
Nanotechnology in fertilizers
MC DeRosa, C Monreal, M Schnitzer, R Walsh, Y Sultan
Nature nanotechnology 5 (2), 91-91, 2010
Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase
S Darvesh, KV Darvesh, RS McDonald, D Mataija, R Walsh, S Mothana, ...
Journal of medicinal chemistry 51 (14), 4200-4212, 2008
Inhibition of human cholinesterases by drugs used to treat Alzheimer disease
S Darvesh, R Walsh, R Kumar, A Caines, S Roberts, D Magee, ...
Alzheimer Disease & Associated Disorders 17 (2), 117-126, 2003
In situ biosensing with a surface plasmon resonance fiber grating aptasensor
Y Shevchenko, TJ Francis, DAD Blair, R Walsh, MC DeRosa, J Albert
Analytical chemistry 83 (18), 7027-7034, 2011
Retention of function in the DNA homolog of the RNA dopamine aptamer
R Walsh, MC DeRosa
Biochemical and biophysical research communications 388 (4), 732-735, 2009
Preparation of functional aptamer films using layer-by-layer self-assembly
Y Sultan, R Walsh, C Monreal, MC DeRosa
Biomacromolecules 10 (5), 1149-1154, 2009
Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine
S Darvesh, RS McDonald, KV Darvesh, D Mataija, S Conrad, G Gomez, ...
Bioorganic & medicinal chemistry 15 (19), 6367-6378, 2007
Structure–activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives
S Darvesh, RS McDonald, A Penwell, S Conrad, KV Darvesh, D Mataija, ...
Bioorganic & medicinal chemistry 13 (1), 211-222, 2005
Differential effects of lipid-lowering agents on human cholinesterases
S Darvesh, E Martin, R Walsh, K Rockwood
Clinical Biochemistry 37 (1), 42-49, 2004
Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants
S Darvesh, IR Pottie, KV Darvesh, RS McDonald, R Walsh, S Conrad, ...
Bioorganic & medicinal chemistry 18 (6), 2232-2244, 2010
On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases
S Darvesh, RS McDonald, KV Darvesh, D Mataija, S Mothana, H Cook, ...
Bioorganic & medicinal chemistry 14 (13), 4586-4599, 2006
Analysis of bacterial, fungal and archaeal populations from a municipal wastewater treatment plant developing an innovative aerobic granular sludge process
J Liu, J Li, Y Tao, B Sellamuthu, R Walsh
World Journal of Microbiology and Biotechnology 33, 1-8, 2017
Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin
S Darvesh, R Kumar, S Roberts, R Walsh, E Martin
Cellular and molecular neurobiology 21, 285-296, 2001
Response to the Article “Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality”
R Walsh
SLAS Discov., 2019
Real-time isothermal DNA amplification monitoring in picoliter volumes using an optical fiber sensor
M Janik, SV Hamidi, M Koba, J Perreault, R Walsh, WJ Bock, M ¦mietana
Lab on a Chip 21 (2), 397-404, 2021
Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram
R Walsh, K Rockwood, E Martin, S Darvesh
Biochimica et Biophysica Acta (BBA)-General Subjects 1810 (12), 1230-1235, 2011
A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters
R Walsh, E Martin, S Darvesh
Biochimica et Biophysica Acta (BBA)-General Subjects 1800 (1), 1-5, 2010
Enzyme-linked DNA dendrimer nanosensors for acetylcholine
R Walsh, JM Morales, CG Skipwith, TT Ruckh, HA Clark
Scientific reports 5 (1), 14832, 2015
Homocysteine thiolactone and human cholinesterases
S Darvesh, R Walsh, E Martin
Cellular and Molecular Neurobiology 27, 33-48, 2007
A versatile equation to describe reversible enzyme inhibition and activation kinetics: Modeling β-galactosidase and butyrylcholinesterase
R Walsh, E Martin, S Darvesh
Biochimica et Biophysica Acta (BBA)-General Subjects 1770 (5), 733-746, 2007
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20